A new PET tracer provides insight into how spinal cord injuries affect both the spinal cord and the brain. This new tracer identifies synapse loss, providing molecularly unique and complementary information to other imaging methods. Read more: jnm.snmjournals.org/content/66/9...

Nine Takeaways from New Guidelines on PET Myocardial Perfusion Imaging www.diagnosticimaging.com/view/nine-ta... #radiology #RadRes #NuclearMedicine

Early and accurate diagnosis of coronary artery disease is critical for improved patient outcomes. @asnc.bsky.social, @eanm.org, ACNM, and SNMMI have developed new guidelines for 18F-flurpiridaz PET myocardial perfusion imaging (MPI) and blood flow quantitation. snmmi.org/Web/News/Art...

For the first time ever, a rare malignant tumor responds to treatment. Read more below, and check out the full article in this month's @journalofnucmed.bsky.social: jnm.snmjournals.org/content/66/9...

SNMMI presented a Joint Symposium at the American Thyroid Association Annual Meeting on September 12. Drs. Mehdi Djekidel (far left) & Seza Gulec (far right) along with ATA members held a panel discussion on best practices related to radioactive iodine treatment of thyroid cancer

Two molecular targets have emerged as promising candidates for the diagnosis and treatment of endometrial cancer: Human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24). jnm.snmjournals.org/content/earl...

Happy September! Whether you're already missing summer or are ready for fall, JNM is always in season. Here are this month's highlights: jnm.snmjournals.org/content/66/9

New in Uptake: PET Amyloid Quantitation Methods for Degree of Amyloid Burden Explore how Z-Scores, Standardized Uptake Value Ratios, and Centiloid Scaling are used. Learn more with our infographic below, or read the full article on our website: snmmi.org/Web/News/Art...

A 5-minute Basal Cell Carcinoma diagnosis is within our reach. A topical fluorescent molecular contrast agent called PARPi-FL can detect basal cell carcinoma through intact skin in as little as 5 minutes in ex vivo human tissue. 🧵👇https://jnm.snmjournals.org/content/66/8/1197

NEW from @journalofnucmed.bsky.social: Men with biochemically resistant prostate cancer who undergo PSMA PET/CT before salvage radiotherapy have improved survival rates over those who do not. Read more here 👇🧵 jnm.snmjournals.org/content/66/8...

SNMMI is proud to launch the Global Radiopharmaceutical Trials Finder. With the help of AI, SNMMI is addressing that gap, bringing nuclear medicine care to your fingertips. Start by answering 2 easy questions: disease area and zip code: snmmi.org/Web/News/Art...

Congratulations David Gilmore, Ed.D., CNMT, RT(R)(N) on receiving the 2025 SNMMI-TS Lifetime Achievement Award for Transformative Contributions to Nuclear Medicine Technology. Read more about his work here: snmmi.org/Web/News/Art...

Summer may be winding down but the @journalofnucmed.bsky.social is hot off the presses! Check out these highlights: 🧵👇 jnm.snmjournals.org/content/66/8

Novel Radioimmunotherapy Eradicates Cancer Stem Cells in Ovarian Cancer Model A new radioimmunotherapy has successfully eliminated cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the gold standard. Read here: jnm.snmjournals.org/content/66/7...

What's better than more science? We're back with Part 2 of the most news-worthy abstracts presented at the 2025 Annual Meeting. Did you miss attending the Annual Meeting? Access the virtual meeting portal until September 15. Click here: web.cvent.com/attendee-log...

A new study using whole-body PET to assess naloxone’s (also known as Narcan) binding to opioid receptors suggests that men and women respond differently to opioid use disorder treatments.

Alzheimer’s and dementia are heartbreaking diseases that slowly erase the minds and memories of our loved ones. As hard as it is on the patient, it’s equally as hard on their caregivers and those who love them. Tune into this episode of the JNMT podcast for more: youtu.be/g5TfvRcmTxU

A new study that included the largest cohort of long COVID subjects with cardio-pulmonary symptoms and the longest follow-up duration found that patients with Long COVID and an abnormal cardiopulmonary PET/MR are more likely to develop heart and lung diseases.

There's no shortage of groundbreaking science presented at the SNMMI Annual Meeting. In case you missed some of these headline-grabbing abstracts, we're highlighting them here.👇🧵

Excited to join Bluesky! I’m a Nuclear Medicine Technology student passionate about medical imaging, patient-centered care, and making connections in healthcare. #NuclearMedicine #NMT #MedicalImaging #StudentJourney @snm-mi.bsky.social

Want to see 2,000 Annual Meeting photos? Here you go! We hope you have as much fun reliving the meeting as we did hosting it. Click here to view the full album: flic.kr/s/aHBqjCiMM4

Congratulations to Professor Andrew Scott AM who received two awards at the SNMMI meeting last week. ➡️ The Minoshima-Pappas award ➡️️ The Henry Wagner Jr lecture award Read more: ow.ly/ExHa50WkR3C @snm-mi.bsky.social‬ #SNMMI2025 #NuclearMedicine #Theranostics #ONJCRI

The July issue of JNM has been published just in time for the holiday weekend! New for this issue, the JNM Editors' Choice Awards for 2024! Read now: jnm.snmjournals.org/content/66/7

SNMMI commends the U.S. Food and Drug Administration (FDA) for recognizing the critical role of nuclear medicine in Alzheimer’s and dementia imaging and therapy. Read more here: snmmi.org/Web/News/Art...

SNMMI President Jean-Luc Urbain talked with Diagnostic Imaging on patient access to nuclear medicine! Full article below: www.diagnosticimaging.com/view/improvi...

New research presented at the @snm-mi.bsky.social ‪annual meeting #SNMMI2025 makes a strong case for a new dual-targeting #radiopharmaceutical, designed to attach to two vulnerable sites on #cancer cells, enabling more precise and potent therapy. #nuclearmedicine

Already missing the 2025 Annual Meeting? (We are!) Before we start counting down the days to next year in Los Angeles, let's take one more look at the highlights from New Orleans youtu.be/UkoEqPUyYg4?...

Congratulations to Vibha Balaji for winning the @snmmi-pidsc.bsky.social Best Poster Award (1st Place) and Fan Yang for a great oral presentation at the @snm-mi.bsky.social conference! Ziyuan Zhou & Bowen Lei did excellent work on their virtual posters. #BIDSLab @umassengineering.bsky.social

The SNMMI Image of the Year is the Society’s most anticipated award. It not only captures the results of a years-long study but also serves as a roadmap to the future for the field of nuclear medicine and molecular imaging.

How is #NuclearMedicine publishing adapting to current challenges? @ucsfimaging.bsky.social's Dr. Thomas Hope joins a panel to discuss opportunities in academic publishing & journal development this afternoon at #SNMMI25. @snm-mi.bsky.social

Massive congratulations to our Steven Liang, the 2025 Sanjiv Gambhir Trailblazer Award winner at #snmmi25! Steven is a real trailblazer in radiopharmacy & radiochemistry. @snm-mi.bsky.social @emoryuniversity.bsky.social

TS President Julie Bolin talks about barriers to education and recent partner scholarships offered by SNMMI:

President Cathy Cutler debriefs on the Theranostics Summit in her beautiful NOLA-themed hat.

Dr. Margie Warrell opens the plenary!

Very happy and thankful to be introduced as a Fwllow of the @snm-mi.bsky.social today. also thanks to the great people in my lab!

A new immuno-PET/CT imaging technique has identified and validated the biomarker CD70, which is highly and constantly expressed in nasopharyngeal cancer (NPC). jnm.snmjournals.org/content/66/6...

Exciting news! @ucsfimaging.bsky.social's Dr. Anil Bidkar has been named to the @snm-mi.bsky.social‬ "Ones to Watch" 2025 list. This honor recognizes early career leaders in nuclear medicine & molecular imaging. Dr. Bidkar's impactful work & dedication make this well-deserved! 👏 bit.ly/45LlM31

In a study published in the June edition of the @journalofnucmed.bsky.social, a new imaging agent was found to be effective at targeting many different subtypes of triple-negative breast cancer (TNBC). jnm.snmjournals.org/content/earl...

The June issue of the @journalofnucmed.bsky.social is out! Check out the highlights: 🧵👇 jnm.snmjournals.org/content/66/6

A @journalofnucmed.bsky.social study found that pairing radiopharmaceutical 177Lu-DOTATATE w/DNA-repair blocker olaparib is tolerable for neuroendocrine tumor (NET) patients. This prevents cancer cells from repairing after being targeted by a radiopharmaceutical. jnm.snmjournals.org/content/66/5...

SNMMI enjoyed the opportunity to collaborate with the American Society of Neuroradiology for a joint session at their Annual Meeting on May 18. About 250 physicians attended to learn "How to Distinguish Your Neuroradiology Practice with Molecular Imaging."

The WHO has issued a resolution aimed at "Strengthening Medical Imaging Capacity," and SNMMI stands strongly in support. Medical imaging is a pillar of modern healthcare, but inequalities that particularly affect low-resource and rural areas persist. snmmi.org/Web/News/Art...

Due to U.S. dependence on foreign medical isotopes, SNMMI has submitted comments to the Department of Commerce to urge the Administration to defer future tariffs so that patients can continue to access lifesaving nuclear medicine scans. Learn more here: snmmi.org/Web/News/Art...

Learn more about nuclear medicine and how the advances in this advanced imaging modality can help you or someone you love. Register for SNMMI Patient Education Day! Attend in person in New Orleans, or online via YouTube! snmmi.org/Web/Educatio...

Last weekend, SNMMI sponsored a summit where nuclear medicine physicians, pharmacists, technologists, and researchers, as well as leaders of peer societies, industry partners, and patients, gathered to further the use of theranostics. Get caught up: snmmi.org/Web/News/Art...

Stanford Medicine is the first to deploy a type of molecular imaging that uses fluorescent dye to illuminate cancerous tissue in the breast during surgery. The system is called the LumiSystem -- learn more here: healthimaging.com/topics/medic...

💫 Sofia Vaz, médica, investigadora e especialista em Medicina Nuclear na Fundação Champalimaud, foi reconhecida pelo programa Ones to Watch 2025 da @snm-mi.bsky.social como um nome a acompanhar na medicina nuclear e na imagiologia molecular. Parabéns, Sofia. 👏

The May issue of the Journal of Nuclear Medicine was just published. Let's dive into the highlights: 🧵 jnm.snmjournals.org/content/66/5

SNMMI is pleased to announce our annual list of early career professionals selected as “Ones to Watch” in 2025. We are proud to showcase rising talent in the field, offering a platform to increase recognition within our specialty. Congratulations to our 2025 honorees! ow.ly/H0x550VKVfZ

Congratulations to #radonc chief resident Jimmy S. Patel, MD, PhD, named to the @snm-mi.bsky.social Ones to Watch 2025 list! Mentored + nominated by Steven Liang, Endowed Dir of Radiochemistry, Cyclotron Facility & Radiopharmacy, Dr. Patel is a gifted physician/investigator. @winshipcancer.emory.edu